CHRYSTAL ROGERS: Open Payments
NPI 1326696907 · CADIZ, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
Products named: REXULTI, INGREZZA, Dexcom G6 Transmitter, Auvelity, ZORYVE.
Industry payments across KY — which companies pay providers there.
